“Creating one of the richest repositories of gastroenterology clinical data with Gastro Health opens up millions of data points for life-changing research,” said Omer Dror, CEO and co-founder of Lynx.MD. “Over 3 million people in the U.S. suffer from IBD and the CDC estimates that up to 15% suffer from IBS. Access to real-world data will advance the development of new therapeutics and treatments that can change the quality of patients’ lives.”
The collaboration will provide Gastro Health with deep, data-informed insights to achieve value-based care goals. And, it will help realize the largest secure, privacy-compliant, real-world GI dataset for researchers around the world.
About Lynx.MD
Lynx.MD is the leading cloud-based platform that unlocks real-world health data at scale. The platform enables the sharing and analysis of rich, unstructured data, securely connecting healthcare organizations with the life sciences and MedTech community. Lynx provides an environment for deep learning studies, enabling researchers to investigate data from multiple sources.
About Gastro Health
Gastro Health is one of the leading gastroenterology platforms in the United States supporting practices in Alabama, Florida, Maryland, Massachusetts, Ohio, Virginia, and Washington. Gastro Health strives to provide outstanding medical care and an exceptional healthcare experience. The Gastro Health care teams utilize technology, clinical expertise, and compassionate care to provide a personalized approach to digestive health and overall wellness.
Back to HCB News
